Ross McAloon advises clients on complex capital markets, securities regulation, and corporate governance matters, particularly in the life sciences and technology industries.

Mr. McAloon helps companies, investment banks, and private equity firms navigate capital markets transactions and related matters involving:

  • International and US-registered offerings, including IPOs
  • Private placements
  • Rights offerings
  • General corporate, securities, and public company matters

He draws on extensive transactional experience in multiple jurisdictions to proactively address client concerns and help them achieve their commercial goals.

Mr. McAloon previously practiced in the firm’s New York and London offices and as a secondee at an international investment bank. While in law school, he served as an articles editor for the American Intellectual Property Law Association Quarterly Journal.

Mr. McAloon’s active pro bono practice includes representing Human Options, an organization that works to protect victims of domestic violence in Orange County.

Mr. McAloon’s experience includes advising: 

Issuer Side

  • Arcutis Biotherapeutics (NASDAQ)
  • Europris (Oslo Stock Exchange)
  • EverCommerce (NASDAQ)
  • Evolution Gaming (NASDAQ Stockholm)
  • CLX Communications (NASDAQ Stockholm)
  • GoodRx (NASDAQ)
  • Inari Medical (NASDAQ)
  • Lifco (NASDAQ Stockholm)
  • Munters Group (NASDAQ Stockholm)
  • Preventice Solutions (acquired by Boston Scientific)
  • Redwood Trust (NYSE)
  • Resurs Holding (NASDAQ Stockholm)
  • RPC Group (London Stock Exchange)
  • Sonendo (NYSE)
  • Swedish Orphan Biovitrum (NASDAQ Stockholm)
  • TI Fluid Systems (London Stock Exchange)
  • Traeger (NYSE)

Underwriter Side

Mr. McAloon’s underwriter clients include Bank of America, Cowen, Credit Suisse, Goldman Sachs, Jefferies, J.P. Morgan, Morgan Stanley, Stifel, and SVB Leerink. Representative matters include:

  • Arcutis Biotherapeutics’ IPO 
  • Cortexyme’s IPO
  • F45 Training’s IPO    
  • Ibstock’s IPO on the London Stock Exchange 
  • Ichor Holdings’ public offerings 
  • Nets’ IPO on NASDAQ Copenhagen
  • Nomad Foods’ private placement
  • Principia Biopharma’s IPO and subsequent public offering
  • PureTech Health’s IPO on the London Stock Exchange
  • Sientra’s public offerings
  • Silk Road Medical’s IPO and subsequent public offerings
  • Telefonica’s rights offering
  • Trupanion’s public offerings
  • Wright Medical’s public offerings and private placements

Bar Qualification

  • California
  • New York


  • Juris Doctor, The George Washington University, 2012
  • Bachelor of Business Administration, Loyola University, 2008

Languages Spoken

  • English